0 XP   0   0   0

Cosmos Holdings Inc










Financial Health of Cosmos Holdings Inc




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings  


Cosmos Holdings Inc
Buy, Hold or Sell?

Should you buy, hold or sell Cosmos Holdings Inc?

I guess you are interested in Cosmos Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Cosmos Holdings Inc

Let's start. I'm going to help you getting a better view of Cosmos Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Cosmos Holdings Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Cosmos Holdings Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Cosmos Holdings Inc. The closing price on 2022-12-02 was $0.535 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Cosmos Holdings Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Cosmos Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cosmos Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -138.3% means that $-1.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cosmos Holdings Inc:

  • The MRQ is -138.3%. The company is making a huge loss. -2
  • The TTM is -54.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-138.3%TTM-54.5%-83.8%
TTM-54.5%YOY-5.2%-49.2%
TTM-54.5%5Y-26.8%-27.7%
5Y-26.8%10Y-32.0%+5.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-138.3%0.4%-138.7%
TTM-54.5%0.3%-54.8%
YOY-5.2%0.2%-5.4%
5Y-26.8%-0.7%-26.1%
10Y-32.0%-0.1%-31.9%
1.1.2. Return on Assets

Shows how efficient Cosmos Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -38.2% Return on Assets means that Cosmos Holdings Inc generated $-0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cosmos Holdings Inc:

  • The MRQ is -38.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.2%TTM-15.9%-22.3%
TTM-15.9%YOY-1.8%-14.1%
TTM-15.9%5Y-10.8%-5.1%
5Y-10.8%10Y-4,420.5%+4,409.7%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.2%0.1%-38.3%
TTM-15.9%0.1%-16.0%
YOY-1.8%-0.1%-1.7%
5Y-10.8%-0.2%-10.6%
10Y-4,420.5%0.1%-4,420.6%
1.1.3. Return on Equity

Shows how efficient Cosmos Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -224.0% Return on Equity means Cosmos Holdings Inc generated $-2.24 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cosmos Holdings Inc:

  • The MRQ is -224.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -126.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-224.0%TTM-126.8%-97.2%
TTM-126.8%YOY-154.7%+27.9%
TTM-126.8%5Y-51.4%-75.4%
5Y-51.4%10Y14.1%-65.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-224.0%0.6%-224.6%
TTM-126.8%0.4%-127.2%
YOY-154.7%0.4%-155.1%
5Y-51.4%-0.3%-51.1%
10Y14.1%0.1%+14.0%

1.2. Operating Efficiency of Cosmos Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cosmos Holdings Inc is operating .

  • Measures how much profit Cosmos Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -134.0% means the company generated $-1.34  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cosmos Holdings Inc:

  • The MRQ is -134.0%. The company is operating very inefficient. -2
  • The TTM is -49.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-134.0%TTM-49.4%-84.5%
TTM-49.4%YOY1.9%-51.3%
TTM-49.4%5Y-12.9%-36.6%
5Y-12.9%10Y-36.8%+24.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-134.0%2.5%-136.5%
TTM-49.4%1.6%-51.0%
YOY1.9%2.7%-0.8%
5Y-12.9%1.8%-14.7%
10Y-36.8%0.8%-37.6%
1.2.2. Operating Ratio

Measures how efficient Cosmos Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are $1.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cosmos Holdings Inc:

  • The MRQ is 1.006. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.238. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.006TTM1.238-0.233
TTM1.238YOY0.991+0.247
TTM1.2385Y1.214+0.024
5Y1.21410Y0.813+0.401
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0061.473-0.467
TTM1.2381.456-0.218
YOY0.9911.398-0.407
5Y1.2141.374-0.160
10Y0.8131.191-0.378

1.3. Liquidity of Cosmos Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cosmos Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.12 means the company has $1.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cosmos Holdings Inc:

  • The MRQ is 1.115. The company is just able to pay all its short-term debts.
  • The TTM is 1.258. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.115TTM1.258-0.142
TTM1.258YOY1.135+0.122
TTM1.2585Y0.967+0.291
5Y0.96710Y1.083-0.116
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1151.880-0.765
TTM1.2581.901-0.643
YOY1.1352.112-0.977
5Y0.9672.182-1.215
10Y1.0831.891-0.808
1.3.2. Quick Ratio

Measures if Cosmos Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.81 means the company can pay off $0.81 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cosmos Holdings Inc:

  • The MRQ is 0.806. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.891. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.806TTM0.891-0.085
TTM0.891YOY0.765+0.126
TTM0.8915Y0.573+0.318
5Y0.57310Y0.639-0.067
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8060.733+0.073
TTM0.8910.796+0.095
YOY0.7650.808-0.043
5Y0.5730.834-0.261
10Y0.6390.821-0.182

1.4. Solvency of Cosmos Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cosmos Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cosmos Holdings Inc to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.83 means that Cosmos Holdings Inc assets are financed with 83.0% credit (debt) and the remaining percentage (100% - 83.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cosmos Holdings Inc:

  • The MRQ is 0.830. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.889. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.830TTM0.889-0.059
TTM0.889YOY1.076-0.188
TTM0.8895Y1.116-0.227
5Y1.11610Y154.720-153.604
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8300.437+0.393
TTM0.8890.424+0.465
YOY1.0760.398+0.678
5Y1.1160.398+0.718
10Y154.7200.401+154.319
1.4.2. Debt to Equity Ratio

Measures if Cosmos Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 486.7% means that company has $4.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cosmos Holdings Inc:

  • The MRQ is 4.867. The company is unable to pay all its debts with equity. -1
  • The TTM is 8.673. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.867TTM8.673-3.806
TTM8.673YOY29.107-20.435
TTM8.6735Y7.804+0.869
5Y7.80410Y4.372+3.432
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8670.652+4.215
TTM8.6730.675+7.998
YOY29.1070.623+28.484
5Y7.8040.684+7.120
10Y4.3720.697+3.675

2. Market Valuation of Cosmos Holdings Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cosmos Holdings Inc generates.

  • Above 15 is considered overpriced but always compare Cosmos Holdings Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -1.71 means the investor is paying $-1.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cosmos Holdings Inc:

  • The EOD is -2.466. Company is losing money. -2
  • The MRQ is -1.705. Company is losing money. -2
  • The TTM is 162.736. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD-2.466MRQ-1.705-0.761
MRQ-1.705TTM162.736-164.442
TTM162.736YOY-133.954+296.690
TTM162.7365Y9.612+153.124
5Y9.61210Y-89.406+99.018
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-2.466-0.124-2.342
MRQ-1.705-0.437-1.268
TTM162.736-0.102+162.838
YOY-133.95415.340-149.294
5Y9.6127.916+1.696
10Y-89.4067.700-97.106
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Cosmos Holdings Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Cosmos Holdings Inc:

  • The MRQ is 1.687. Seems overpriced? -1
  • The TTM is -206.003. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ1.687TTM-206.003+207.690
TTM-206.003YOY581.793-787.796
TTM-206.0035Y-187.692-18.311
5Y-187.69210Y-243.530+55.838
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6870.012+1.675
TTM-206.0030.010-206.013
YOY581.7930.004+581.789
5Y-187.6920.010-187.702
10Y-243.5300.021-243.551

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cosmos Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 3.82 means the investor is paying $3.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cosmos Holdings Inc:

  • The EOD is 5.523. Seems overpriced? -1
  • The MRQ is 3.820. Neutral. Compare to industry.
  • The TTM is 48.476. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD5.523MRQ3.820+1.703
MRQ3.820TTM48.476-44.656
TTM48.476YOY219.658-171.182
TTM48.4765Y4.601+43.875
5Y4.60110Y-101.248+105.849
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD5.5231.415+4.108
MRQ3.8201.586+2.234
TTM48.4762.019+46.457
YOY219.6582.230+217.428
5Y4.6011.895+2.706
10Y-101.2481.505-102.753
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cosmos Holdings Inc.

3.1. Institutions holding Cosmos Holdings Inc

Institutions are holding 6.021% of the shares of Cosmos Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Murchinson Ltd.0.87770.054977657077507051671.3333
2022-06-30Anson Funds Management LP0.76390.02336759086759080
2022-06-30Virtu Financial LLC0.09940.00288796971799444.026
2022-06-30Tower Research Capital LLC0.02450.000221664216640
2022-09-30Washington Trust Co0.00170150015000
2022-06-30Wells Fargo & Co0.0001061610
2022-06-30Hudson Bay Capital Management LP000-755802-100
2022-06-30TWO SIGMA SECURITIES, LLC000-10200-100
Total 1.76730.08121563672+780000+49.9%

3.2. Funds holding Cosmos Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30SSgA U.S. Extended Market Index Class I0.01470.000113040130400
2022-09-30State St US Extended Mkt Indx NL Cl C0.01470.00011304000
2022-09-30SSgA U.S. Total Market Index Strategy0.00460403740370
2022-09-30Fidelity® NASDAQ Composite Index®0.00160138400
Total 0.03560.000231501+17077+54.2%

3.3. Insider Transactions

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-10-20Grigorios SiokasBUY125000000.1219334168
2021-04-27Grigorios SiokasSELL5975321.22 
2021-01-20Grigorios SiokasSELL1154900.95 
2020-07-29Grigorios SiokasSELL790000.69 
2019-09-06Grigorios SiokasSELL346660.74 
2019-06-24Grigorios SiokasBUY733347.5
2019-06-18Grigorios SiokasSELL300004.13
2019-05-28Grigorios SiokasBUY666677.5
2019-02-27Grigorios SiokasSELL374003.06
2018-12-20Grigorios SiokasSELL5443003.27
2018-10-30Grigorios SiokasSELL1917751.73
2018-10-25Grigorios SiokasSELL718753.97
2018-07-09Grigorios SiokasSELL895671.33
2018-03-30Grigorios SiokasSELL2594803.63
2018-03-28Grigorios SiokasSELL477502.83
2017-10-23Grigorios SiokasSELL1700000.52
2017-10-16Grigorios SiokasSELL6374200.14
2017-05-31Grigorios SiokasSELL9945000.195596133
2017-04-05Grigorios SiokasSELL15778000.1297495933
2017-03-02Grigorios SiokasSELL13667330.0999047666

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cosmos Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0450.023+94%0.018+155%0.006+600%0.002+1716%
Book Value Growth--0.4630.330+40%3.031-85%0.643-28%0.587-21%
Book Value Per Share--0.0970.064+51%-0.038+139%-0.022+122%-0.007+107%
Book Value Per Share Growth--0.4630.330+40%3.031-85%0.643-28%0.587-21%
Current Ratio--1.1151.258-11%1.135-2%0.967+15%1.083+3%
Debt To Asset Ratio--0.8300.889-7%1.076-23%1.116-26%154.720-99%
Debt To Equity Ratio--4.8678.673-44%29.107-83%7.804-38%4.372+11%
Dividend Per Share--0.0690.040+73%-+100%0.008+763%0.004+1625%
Dividend Per Share Growth---0.3190.341-194%--0.341-194%0.341-194%
Eps---0.217-0.086-60%-0.014-94%-0.029-87%-0.015-93%
Eps Growth---1.01111.052-109%-0.858-15%5.498-118%4.587-122%
Gross Profit Margin--1.0131.013+0%1.0150%1.006+1%0.953+6%
Net Profit Margin---1.383-0.545-61%-0.052-96%-0.268-81%-0.320-77%
Operating Margin---1.340-0.494-63%0.019-7188%-0.129-90%-0.368-72%
Operating Ratio--1.0061.238-19%0.991+1%1.214-17%0.813+24%
Pb Ratio5.523+31%3.82048.476-92%219.658-98%4.601-17%-101.248+2751%
Pe Ratio-2.466-45%-1.705162.736-101%-133.954+7754%9.612-118%-89.406+5142%
Peg Ratio--1.687-206.003+12314%581.793-100%-187.692+11228%-243.530+14538%
Price Per Share0.535+31%0.3702.633-86%4.918-92%4.097-91%2.396-85%
Price To Total Gains Ratio4.709+31%3.257-231.585+7211%398.078-99%284953.321-100%161546.463-100%
Profit Growth---50.147-19.896-60%-84.498+69%138.833-136%217.816-123%
Quick Ratio--0.8060.891-10%0.765+5%0.573+41%0.639+26%
Return On Assets---0.382-0.159-58%-0.018-95%-0.108-72%-44.205+11479%
Return On Equity---2.240-1.268-43%-1.547-31%-0.514-77%0.141-1684%
Revenue Growth---0.225-0.039-83%0.032-801%0.029-884%-0.965+329%
Total Gains Per Share--0.1140.063+81%0.018+547%0.014+690%0.006+1660%
Total Gains Per Share Growth--0.202-3.886+2025%0.175+16%98.934-100%792.105-100%
Usd Book Value--8154663.0005391137.500+51%-3176870.000+139%-1818675.500+122%-564352.125+107%
Usd Book Value Change Per Share--0.0450.023+94%0.018+155%0.006+600%0.002+1716%
Usd Book Value Per Share--0.0970.064+51%-0.038+139%-0.022+122%-0.007+107%
Usd Dividend Per Share--0.0690.040+73%-+100%0.008+763%0.004+1625%
Usd Eps---0.217-0.086-60%-0.014-94%-0.029-87%-0.015-93%
Usd Price Per Share0.535+31%0.3702.633-86%4.918-92%4.097-91%2.396-85%
Usd Profit---18263957.000-7694456.750-58%-820838.000-96%-2907143.400-84%-1492540.000-92%
Usd Revenue--13208504.00014790104.500-11%15450265.250-15%11923115.750+11%6719900.325+97%
Usd Total Gains Per Share--0.1140.063+81%0.018+547%0.014+690%0.006+1660%
 EOD+3 -2MRQTTM+20 -16YOY+17 -185Y+19 -1710Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Cosmos Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.466
Price to Book Ratio (EOD)Between0-15.523
Net Profit Margin (MRQ)Greater than0-1.383
Operating Margin (MRQ)Greater than0-1.340
Quick Ratio (MRQ)Greater than10.806
Current Ratio (MRQ)Greater than11.115
Debt to Asset Ratio (MRQ)Less than10.830
Debt to Equity Ratio (MRQ)Less than14.867
Return on Equity (MRQ)Greater than0.15-2.240
Return on Assets (MRQ)Greater than0.05-0.382
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Cosmos Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.467
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets47,842
Total Liabilities39,688
Total Stockholder Equity8,155
 As reported
Total Liabilities 39,688
Total Stockholder Equity+ 8,155
Total Assets = 47,842

Assets

Total Assets47,842
Total Current Assets40,000
Long-term Assets40,000
Total Current Assets
Cash And Cash Equivalents 562
Short-term Investments 10
Net Receivables 28,891
Inventory 7,716
Other Current Assets 1,095
Total Current Assets  (as reported)40,000
Total Current Assets  (calculated)38,275
+/- 1,725
Long-term Assets
Property Plant Equipment 1,619
Goodwill 50
Intangible Assets 691
Other Assets 5,325
Long-term Assets  (as reported)7,843
Long-term Assets  (calculated)7,686
+/- 157

Liabilities & Shareholders' Equity

Total Current Liabilities35,871
Long-term Liabilities3,816
Total Stockholder Equity8,155
Total Current Liabilities
Short Long Term Debt 20,247
Accounts payable 11,204
Other Current Liabilities 2,279
Total Current Liabilities  (as reported)35,871
Total Current Liabilities  (calculated)33,729
+/- 2,142
Long-term Liabilities
Long term Debt 1,371
Capital Lease Obligations Min Short Term Debt1,105
Long-term Liabilities Other 1,555
Long-term Liabilities  (as reported)3,816
Long-term Liabilities  (calculated)4,031
+/- 215
Total Stockholder Equity
Common Stock24
Other Stockholders Equity -1,586
Total Stockholder Equity (as reported)8,155
Total Stockholder Equity (calculated)-1,562
+/- 9,716
Other
Capital Stock3,049
Common Stock Shares Outstanding 19,540
Net Debt 21,056
Net Invested Capital 26,748
Net Tangible Assets 4,389
Net Working Capital 4,128



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-03-312011-12-312011-09-302011-03-312010-12-312010-09-302010-03-312009-12-312009-09-30
> Total Assets 
0
15
10
0
1
61
15
0
2
0
0
6
19
501
867
867
2,104
7,220
7,235
7,235
6,423
6,480
658
658
890
2,106
3,119
3,119
7,249
10,835
10,676
10,676
13,583
19,506
20,695
20,695
21,830
21,280
23,880
23,880
33,855
38,569
43,844
43,844
45,157
47,677
49,429
49,429
47,842
47,84249,42949,42947,67745,15743,84443,84438,56933,85523,88023,88021,28021,83020,69520,69519,50613,58310,67610,67610,8357,2493,1193,1192,1068906586586,4806,4237,2357,2357,2202,104867867501196002015611010150
   > Total Current Assets 
0
15
10
0
1
61
15
0
2
0
0
6
19
501
0
865
2,104
7,214
0
7,213
6,367
6,402
0
547
764
1,933
2,637
2,637
6,628
10,055
9,511
9,511
12,961
19,223
18,347
18,347
19,036
18,601
21,179
21,179
31,218
35,876
40,773
40,773
42,315
44,284
40,879
40,879
40,000
40,00040,87940,87944,28442,31540,77340,77335,87631,21821,17921,17918,60119,03618,34718,34719,22312,9619,5119,51110,0556,6282,6372,6371,93376454706,4026,3677,21307,2142,1048650501196002015611010150
       Cash And Cash Equivalents 
0
15
5
0
1
61
15
0
0
0
0
6
19
501
864
864
841
84
447
7,180
6,334
156
198
198
474
620
716
717
780
1,352
783
783
1,154
1,233
864
864
887
1,180
39
39
2,407
1,082
628
628
806
1,034
286
286
562
5622862861,0348066286281,0822,40739391,1808878648641,2331,1547837831,3527807177166204741981981566,3347,1804478484186486450119600001561105150
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,826
6,275
2,717
2,717
1,173
405
243
243
254
211
223
223
216
211
7
7
10
10772112162232232112542432434051,1732,7172,7176,2751,82600000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,228
62
0
0
0
0
0
97
126
553
794
794
2,225
2,859
1,427
1,427
1,999
2,415
4,943
4,943
5,756
6,205
9,268
9,268
15,282
19,726
26,909
26,909
28,679
30,114
30,137
26,858
28,891
28,89126,85830,13730,11428,67926,90926,90919,72615,2829,2689,2686,2055,7564,9434,9432,4151,9991,4271,4272,8592,2257947945531269700000621,2280000000000000000
       Other Current Assets 
0
0
5
0
0
0
0
0
1
0
0
0
0
0
3
0
35
7,067
6,766
33
33
6,246
61
61
0
379
663
662
2,253
3,748
4,207
4,207
5,906
6,874
4,867
6,620
7,597
7,331
665
8,155
9,587
10,655
9,720
9,720
9,083
9,331
1,046
10,580
1,095
1,09510,5801,0469,3319,0839,7209,72010,6559,5878,1556657,3317,5976,6204,8676,8745,9064,2074,2073,7482,253662663379061616,24633336,7667,067350300000100000500
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
7
0
22
56
78
0
110
126
173
0
482
621
780
0
1,165
622
283
0
2,348
2,794
2,679
2,701
2,701
2,637
2,693
3,071
3,071
2,842
3,394
8,551
8,551
7,843
7,8438,5518,5513,3942,8423,0713,0712,6932,6372,7012,7012,6792,7942,34802836221,1650780621482017312611007856220702000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
46
39
51
51
56
57
53
53
73
80
114
115
125
125
1,426
1,426
1,710
1,638
1,735
1,735
1,675
1,700
1,757
1,757
1,578
1,969
1,881
1,881
1,619
1,6191,8811,8811,9691,5781,7571,7571,7001,6751,7351,7351,6381,7101,4261,426125125115114807353535756515139461212000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
5050505050505050505050505050500000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
48
46
44
42
40
44
36
247
195
233
226
214
214
197
189
181
181
164
459
443
415
691
69141544345916418118118919721421422623319524736444042444648000000020000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
10
13
11
39
60
67
70
116
429
607
548
700
1,051
1,189
534
122
625
616
801
765
702
690
546
578
900
1,076
872
743
6,007
5,904
5,325
5,3255,9046,0077438721,0769005785466907027658016166251225341,1891,05170054860742911670676039111310700000000000000000
> Total Liabilities 
0
17
18
18
16
5
20
117
162
213
339
301
359
1,404
921
921
678
1,526
1,761
1,761
1,613
1,714
1,906
1,905
2,342
3,670
4,872
4,871
9,880
13,602
13,704
13,704
17,013
16,231
24,012
24,012
26,614
27,665
30,340
30,340
39,382
43,339
48,005
48,005
44,773
43,026
45,050
45,050
39,688
39,68845,05045,05043,02644,77348,00548,00543,33939,38230,34030,34027,66526,61424,01224,01216,23117,01313,70413,70413,6029,8804,8714,8723,6702,3421,9051,9061,7141,6131,7611,7611,5266789219211,404359301339213162117205161818170
   > Total Current Liabilities 
0
17
18
18
0
5
20
117
162
213
339
301
359
1,404
921
921
678
1,526
1,761
1,761
1,613
1,664
1,906
1,905
2,342
3,670
4,872
4,871
9,880
13,602
13,704
13,704
15,459
14,676
22,274
22,274
24,542
25,631
28,241
28,241
37,292
41,209
34,793
34,793
31,898
37,427
29,928
29,928
35,871
35,87129,92829,92837,42731,89834,79334,79341,20937,29228,24128,24125,63124,54222,27422,27414,67615,45913,70413,70413,6029,8804,8714,8723,6702,3421,9051,9061,6641,6131,7611,7611,5266789219211,40435930133921316211720501818170
       Short-term Debt 
0
16
16
0
0
5
5
12
15
125
154
125
0
0
0
165
165
165
0
504
536
540
0
441
802
2,265
3,199
3,199
6,675
9,950
10,179
10,179
11,722
11,990
0
15,023
17,480
18,425
18,653
18,851
27,116
30,370
20,492
20,492
16,581
23,170
0
6,519
0
06,519023,17016,58120,49220,49230,37027,11618,85118,65318,42517,48015,023011,99011,72210,17910,1799,9506,6753,1993,1992,265802441054053650401651651650001251541251512550016160
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,199
3,413
6,675
9,950
10,179
13,704
0
0
0
15,335
17,284
18,249
18,653
20,967
26,974
30,224
20,663
17,758
16,332
22,915
13,345
14,113
20,247
20,24714,11313,34522,91516,33217,75820,66330,22426,97420,96718,65318,24917,28415,33500013,70410,1799,9506,6753,4133,19900000000000000000000000000
       Accounts payable 
0
0
0
2
0
0
0
0
0
3
185
176
219
754
530
717
249
261
159
165
106
86
337
229
176
272
592
592
1,973
2,338
2,166
1,778
1,914
2,031
6,024
5,933
6,605
6,930
8,802
8,562
9,629
10,193
11,974
11,974
12,450
11,712
12,325
12,127
11,204
11,20412,12712,32511,71212,45011,97411,97410,1939,6298,5628,8026,9306,6055,9336,0242,0311,9141,7782,1662,3381,973592592272176229337861061651592612497175307542191761853000002000
       Other Current Liabilities 
0
1
3
16
0
0
20
105
147
210
0
0
140
150
188
38
264
1,100
6
1,091
971
1,038
62
1,173
1,364
1,133
1,081
1,081
1,232
1,314
1,420
1,747
1,822
655
1,227
251
360
7,005
589
582
393
627
2,304
2,304
2,083
1,798
2,626
9,958
2,279
2,2799,9582,6261,7982,0832,3042,3046273935825897,0053602511,2276551,8221,7471,4201,3141,2321,0811,0811,1331,3641,173621,0389711,09161,1002643818815014000210147105200016310
   > Long-term Liabilities 
0
0
0
16
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0
0
1,555
1,555
0
1,738
2,072
2,034
2,099
2,099
2,091
2,131
13,212
13,212
12,875
5,599
15,122
18,311
3,816
3,81618,31115,1225,59912,87513,21213,2122,1312,0912,0992,0992,0342,0721,73801,5551,55500000000005000000000000000001616000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
184
165
168
165
109
107
109
114
107
103
104
101
0
0
0
0001011041031071141091071091651681651840000000000000000000000000000000000
> Total Stockholder Equity
0
-2
-8
-17
-15
56
-5
-117
-160
-213
-339
-295
-340
-903
0
-54
1,426
5,695
5,474
5,474
4,811
4,766
0
-1,248
-1,452
-1,564
-1,753
-1,753
-2,631
-2,767
-3,028
-3,028
-3,431
3,275
-3,317
-3,317
-4,784
-6,385
-6,461
-6,461
-5,528
-4,770
-4,161
-4,161
385
4,651
4,379
4,379
8,155
8,1554,3794,3794,651385-4,161-4,161-4,770-5,528-6,461-6,461-6,385-4,784-3,317-3,3173,275-3,431-3,028-3,028-2,767-2,631-1,753-1,753-1,564-1,452-1,24804,7664,8115,4745,4745,6951,426-540-903-340-295-339-213-160-117-556-15-17-8-20
   Common Stock
0
20
21
24
24
25
25
25
25
25
25
25
25
126
126
126
126
126
126
126
126
126
126
126
126
126
126
126
128
128
13
13
13
13
14
14
13
13
13
13
13
13
13
13
17
17
18
18
24
241818171713131313131313131414131313131281281261261261261261261261261261261261261261261262525252525252525242421200
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-52
-73
-3,793
-3,813
-3,901
-3,962
-4,178
-4,233
-4,293
-4,535
-4,593
0
-16
0
11
-56
-540
0
-681
-1,131
-1,075
0
-1,106
-1,127
-1,144
0
-1,050
-1,177
-1,229
0
-1,385
-1,339
-34
0
33
62
151
0
-16
23
103
855
855
382
167
0
-152
0
0-152016738285585510323-16015162330-34-1,339-1,3850-1,229-1,177-1,0500-1,144-1,127-1,1060-1,075-1,131-6810-540-56110-160-4,593-4,535-4,293-4,233-4,178-3,962-3,901-3,813-3,793-73-520
   Capital Surplus 0000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000-96-96000000000000000000000000000000
   Other Stockholders Equity 
0
29
45
3,751
3,774
3,933
3,933
4,036
4,048
4,055
4,172
4,274
4,272
-435
0
-433
-428
-425
0
-258
-229
-229
0
133
134
134
-1,050
174
2,293
2,410
-1,385
5,557
7,380
9,574
33
12,908
13,171
13,114
-16
13,114
13,114
13,034
13,721
13,721
23,290
29,707
-152
38,859
-1,586
-1,58638,859-15229,70723,29013,72113,72113,03413,11413,114-1613,11413,17112,908339,5747,3805,557-1,3852,4102,293174-1,0501341341330-229-229-2580-425-428-4330-4354,2724,2744,1724,0554,0484,0363,9333,9333,7743,75145290



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.